07-10-2024 13:21
via
news.google.com
AstraZeneca to license CSPC Pharmaceutical’s lipid-lowering therapy - Pharmaceutical Business Review
AstraZeneca to license CSPC Pharmaceutical’s lipid-lowering therapy Pharmaceutical Business Review
Read more »